Joon Sang Lee

Title: Joon Sang Lee: Innovator in Breast Cancer Treatment Monitoring

Introduction

Joon Sang Lee is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment, particularly in monitoring the effectiveness of endocrine therapy in breast cancer patients. His innovative approach has the potential to improve patient outcomes through personalized treatment strategies.

Latest Patents

Joon Sang Lee holds a patent for a "Panel of ER regulated genes for use in monitoring endocrine therapy in breast cancer." This patent describes a method for assessing the response of individuals with cancer to treatment with amcenestrant. The method involves determining a first ER activity score from a sample taken before treatment and a second score after treatment. By comparing these scores, a decrease in the second score relative to the first indicates effective target engagement of amcenestrant.

Career Highlights

Currently, Joon Sang Lee is associated with Sanofi, a global healthcare company. His work at Sanofi focuses on advancing cancer treatment methodologies and enhancing the precision of therapeutic interventions. His dedication to research and innovation has positioned him as a key figure in the fight against breast cancer.

Collaborations

Some of his notable coworkers include Monsif Bouaboula and Vasiliki Pelekanou. Their collaborative efforts contribute to the ongoing research and development of effective cancer therapies.

Conclusion

Joon Sang Lee's contributions to cancer treatment monitoring exemplify the impact of innovative thinking in healthcare. His patent and work at Sanofi highlight the importance of personalized medicine in improving patient care.